---
title: The Impact of Clinical Factors and SARS-CoV-2 Variants on Antibody Production
  in Vaccinated German Healthcare Professionals Infected Either with the Delta or
  the Omicron Variant
date: '2024-02-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38400146/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240224170845&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Our study identified variant-specific differences in the
  amount of SARS-CoV-2 antibody production and COVID-19 symptoms. Despite this, vaccinated
  individuals with Omicron or Delta infections generally experienced mild disease
  courses. Additionally, asymptomatic individuals exhibit lower anti-SARS-CoV-2 antibody
  levels, indicating a clinical correlation between disease-specific antibodies and
  distinct symptoms, particularly in the case of the Delta variant. In follow-up ...'
disable_comments: true
---
CONCLUSION: Our study identified variant-specific differences in the amount of SARS-CoV-2 antibody production and COVID-19 symptoms. Despite this, vaccinated individuals with Omicron or Delta infections generally experienced mild disease courses. Additionally, asymptomatic individuals exhibit lower anti-SARS-CoV-2 antibody levels, indicating a clinical correlation between disease-specific antibodies and distinct symptoms, particularly in the case of the Delta variant. In follow-up ...